Answers are grounded in this paper and cite their sources.
Abstract Long-term Parkinson's disease (PD) progression is not a homogeneous process and manifests in diverse ways over the lifetime. Recognition of progression benchmarks and their substrates is important for treatment and addressing the expectations of patients, as well as for PD research planning.
No takes yet. Share an insight, caveat, or question.
J. Eric Ahlskog (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: